CRC cells may inhibit cellular ferroptosis through the KIF20A/NUAK1/PP1β/GPX4 pathway, and this may also contribute to the resistance of CRC to oxaliplatin. This evidence concerns the gene NUAK1 and colorectal carcinoma.